Tecan is pleased to announce that Attana AB, a developer of biosensors, represented solely by Tecan US Inc. in North America, will be featured in Today in America with Terry Bradshaw in a series on topics, trends, and issues related to improving diagnostic outcomes through biosensor technology as part of the show’s ‘Medical Minutes’ series.
The program will focus on the complexities of the human body and the costly and time consuming process of drug development. Having access to biologically relevant information, i.e. experimental data that mimics the conditions of the human body as closely as possible, is crucial for finding the best new drug candidate. The Attana Cell 200 biosensor has the unique ability to measure molecular interactions directly on human cells and provides critical data to the drug development process.
For every new drug on the market, thousands of candidate molecules have failed during the research and test phases. The later in the process a candidate fails, the more time and money is spent on it. When a candidate reaches the clinical phase with human test subjects, the costs increase significantly. Therefore, a drug that is thoroughly evaluated before it enters clinical trials risks less significant consequences.
Attana’s technology provides biologically relevant information that enables selection of the good candidates and sorts out the unsuitable ones earlier in the drug development process. Biologically relevant information is crucial for the drug development process – it helps save both time and money in finding the best new drug candidate.
For a preview of the show, click here.
The segment will be aired on March 5th, nationally in North America on Fox Business Network (4:00 PM ET, 3:00 PM CT, 2:00 PM MT, 1:00 PM PT) and on March 11th on CNN Headline News (Comcast Cable, Seattle- Tacoma, 2:24 pm, 3:24 pm, 5:54 pm, 6:24 pm). The Today in America program is an independent production hence not a Fox Business Network or CNN Headline News production.
No comments:
Post a Comment